Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.
about
Hepatitis C: a review for primary care physiciansThe treatment of patients with HIVKASL clinical practice guidelines: management of hepatitis CHepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationCellular and molecular mechanisms in the pathogenesis of liver fibrosis: An updateEffect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patientsTherapeutic issues in HIV/HCV-coinfected patientsCoinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical OutcomesHighly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infectionUnhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis CHuman immunodeficiency virus and liver disease forum 2010: conference proceedingsHepatitis C virus infection.Challenges in the treatment of HIV and HCV coinfection.HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscapeCause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection TreatmentMeta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjectsWithin-host dynamics of the hepatitis C virus quasispecies population in HIV-1/HCV coinfected patients.Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patientsViral hepatitis in HIV infection.Treatment of hepatitis C virus infectionHepatitis C virus infection in the human immunodeficiency virus infected patient.Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theCrosstalk between HIV and hepatitis C virus during co-infectionImpact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection.Liver disease in the HIV-infected individual.Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.Liver transplantation in HCV/HIV positive patients.Care at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic.Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.HCV and HIV co-infection: mechanisms and management.High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda.Coinfection with HIV-1 and HCV--a one-two punch.Liver transplant outcomes in HIV+ haemophilic men.Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study.
P2860
Q22306040-60E7B7CE-2FA7-4E0C-99BB-1B798DFBF564Q24597485-A1C07DC8-930B-4CA3-AA3E-AA8152F38332Q26752471-8BBDCC3E-0D98-4E6B-8067-9839B87E1E28Q26798469-FE838924-9240-4A87-946C-7C78E3460C4FQ26864478-1A7867EC-6FC7-4EC0-B6DD-3D2CA0B7D74CQ27027703-0B5534FD-7ED6-4E8A-BBF1-41C47F86C4E5Q27470167-1FB55402-2019-4314-9C67-F8C3FE24CEEAQ27481053-21A0EBAA-1F80-4C19-9EDF-0782985DB732Q27488883-EDE81B72-74DA-40E6-9DB4-1C82172DF2F7Q27489103-639BC2F4-0F6B-4460-BFEB-8E8C6454DB48Q28484313-A4E4FCEF-0F70-4214-93EC-53C93C8238AAQ28674930-79539ED6-CD28-42E2-885C-77B9DA8DA9DFQ30235491-36F8DB93-BA57-4A8C-86D6-8585702A6CFDQ30389282-A8DFB62D-17F7-46BA-A2B1-2D276DC10A35Q31012317-B895921F-6718-477E-9E66-9899C943904FQ33294712-81BFC37D-C355-4D87-83E2-53E489E044BAQ33576161-FA87CCE7-6980-42D2-9A7E-1BD496A6EAFCQ33585762-624254C1-CB0B-40EB-8F90-7B9F9FED3D34Q33802781-C4806C3D-6406-4E2B-B383-EA6411064FE7Q33815695-A204FE2E-340F-428F-B9DD-C633B62FF3F7Q33946635-4583AA17-D12A-4355-8FE2-FFBECC4A6F54Q34086980-05AF7B78-D50C-4A4B-ADF0-D50046215B75Q34099424-7A008E15-6FA9-4040-82E9-68323EA6E401Q34168504-A14D85AF-8A41-434A-BE8B-702358E95B29Q34209648-BD2679B6-B5A6-483E-A76B-6CD6F1734AC4Q34212799-8D921769-CE1A-4770-A0D4-20C592042B83Q34218972-7D926B3C-E493-4290-9699-BE9CD3E5C56BQ34345002-BC0041CA-7C85-42F8-AD6F-8D2B42F316BFQ34349036-B9A7DB84-26AA-468E-A89C-BDA7EB9A324EQ34380326-709485AA-0409-402B-BCB9-3FE3EC0DAEB1Q34626591-ADF0CCE8-D73F-4F67-B353-1BFC91744B14Q34640985-1B0E5DA3-F7E2-4E7E-8C36-16ECE116CD78Q34702334-3F74B5AE-123D-46C0-9AA7-806FF379BA2CQ35042619-80C93CF9-8BA8-4061-B427-BECB5F22A3D2Q35079868-2F4EFFA0-2161-45B9-8062-BCB15FA0CEEEQ35090634-6762631E-7466-45C0-B024-DBBE7F3F9666Q35125231-2272FD77-3002-4673-9B37-FB915CC8F29AQ35137038-E06BEE24-DDAE-4DC7-AF05-E3AB6BACCE26Q35153955-C4895A91-724F-45F7-8ADF-3CB5FEB69343Q35156330-3D987353-7514-4C59-963E-11A2B90B4C50
P2860
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effect of antiretroviral thera ...... hepatitis C virus coinfection.
@en
Effect of antiretroviral thera ...... hepatitis C virus coinfection.
@nl
type
label
Effect of antiretroviral thera ...... hepatitis C virus coinfection.
@en
Effect of antiretroviral thera ...... hepatitis C virus coinfection.
@nl
prefLabel
Effect of antiretroviral thera ...... hepatitis C virus coinfection.
@en
Effect of antiretroviral thera ...... hepatitis C virus coinfection.
@nl
P2093
P1433
P1476
Effect of antiretroviral thera ...... hepatitis C virus coinfection.
@en
P2093
Bernd Kupfer
Christina Kreuzberg
Guido Lüchters
Nazifa Qurishi
Tilman Sauerbruch
Ulrich Spengler
Wolfgang Effenberger
P304
P356
10.1016/S0140-6736(03)14844-1
P407
P577
2003-11-01T00:00:00Z